Norco
Sponsors
Pfizer, The University of Texas Health Science Center, Houston, Loma Linda University, NYU Langone Health, Charleston Laboratories, Inc
Conditions
HealthyNauseaNon-steroidal Ant Inflammatory DrugsOpioid UseOutpatient SurgeryPainPain ControlPain Control After Functional Endoscopic Sinus Surgery and Septoplasty
Phase 1
Phase 3
Patient Narcotic Requirements After Outpatient Otolaryngology Procedures
CompletedNCT03404518
Start: 2018-02-21End: 2018-10-01Updated: 2022-03-16
A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
CompletedNCT03657810
Start: 2017-08-02End: 2018-11-30Updated: 2023-03-22
Phase 4
Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section
CompletedNCT03372382
Start: 2017-12-13End: 2018-04-10Updated: 2019-07-02
Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty
CompletedNCT03457116
Start: 2018-01-30End: 2020-11-02Updated: 2021-11-23
Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty
CompletedNCT03605914
Start: 2018-08-01End: 2020-07-05Updated: 2021-07-20
RCT: Suzetrigine vs Norco for Post-op Pain
Not yet recruitingNCT07195669
Start: 2025-10-01End: 2026-01-30Target: 76Updated: 2025-09-29